ATAC Sequencing Test – Epigenetic Chromatin Accessibility Profiling | Dubai, UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic-grade reproducibility via ISO-accredited NGS processing and validated bioinformatics pipeline.
Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Post-test telephonic interpretation support from our Consultant Medical Genetics.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

ATAC Sequencing (Assay for Transposase-Accessible Chromatin) is a cutting-edge NGS-based epigenetic assay that maps genome-wide open chromatin regions to identify regulatory elements driving gene expression. This test delivers high-resolution data essential for oncology research, precision medicine, and biomarker discovery. DNA Labs UAE, DHA-licensed (Facility #1143) and ISO 9001:2015 certified, offers this test at 6,500 AED with a 5-week turnaround, supported by VIP mobile phlebotomy and cold-chain logistics for home or clinic collection.

Test Overview & Methodology

ATAC-Seq employs a hyperactive transposase that simultaneously fragments and tags open chromatin regions with sequencing adapters, enabling genome-wide profiling of chromatin accessibility. Our validated bioinformatics pipeline identifies peaks, differential accessibility, and transcription factor footprints, empowering researchers and clinicians to decode epigenetic regulation in cancer and other complex diseases. The assay requires 2–4 mL whole blood in EDTA or ≥2 µg high-quality extracted DNA and delivers reproducible, research-grade data with 99.9% sensitivity.

Feature	Our ATAC-Seq Test	Closest Alternative
Methodology	High-sensitivity transposase-based NGS with validated bioinformatics pipeline	Basic ATAC-seq protocol, variable library quality
Turnaround Time	5 weeks	8–10 weeks
Price	6,500 AED	~7,000 AED
Accreditation	ISO 9001:2015, DHA licensed, validated bioinformatics	Often uncertified or research-only protocol

Physician Insight & Safety Protocols

As a Consultant in Medical Genetics, I view ATAC-Seq as a transformative research tool that illuminates the epigenetic landscape of disease. However, these findings must be interpreted within the full clinical context and discussed with your treating physician before any therapeutic application. Every result prompts a conversation, not a decision.

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication & Treatment Advisory

⚠️ Do not discontinue prescribed medication or alter your treatment plan based solely on ATAC-Seq results. Always consult your treating physician before making any clinical decisions.

Exclusion Criteria & Emergency Red Flags

Critical Safety Information

This test is for research use only; it is not a standalone diagnostic tool.
Requires ≥2 µg high-quality extracted DNA or 2–4 mL whole blood in EDTA tube; heparin contamination invalidates results.
Patients with active bleeding disorders or severe anemia should consult their physician before blood collection.
If you experience acute chest pain, severe headache, shortness of breath, or uncontrolled bleeding—seek emergency care immediately; do not delay for this test.

Patient FAQ & Clinical Guidance

1. What is ATAC Sequencing used for?

ATAC Sequencing identifies open chromatin regions to map genome-wide gene regulation, aiding in cancer research, epigenetic studies, and personalized medicine. It reveals which parts of the genome are actively accessible to transcription factors and regulatory proteins.

2. Is a doctor’s referral required for ATAC sequencing in Dubai?

A physician or researcher referral is strongly recommended to ensure that ATAC sequencing aligns with your clinical or research objectives. Our genetics team can assist in determining appropriateness before sample collection.

3. How accurate is the ATAC sequencing performed at your laboratory?

Our ISO 9001:2015 certified facility achieves 99.9% diagnostic-grade reproducibility with validated quality metrics, surpassing standard research-grade assays. Each batch undergoes stringent internal controls and bioinformatics validation.

4. How should I prepare for the blood collection?

No special preparation is needed. If you are having whole blood drawn, a standard EDTA tube (purple top) is required. Avoid heparin-containing tubes as they interfere with the transposase reaction. Stay hydrated and inform the phlebotomist of any bleeding concerns.

5. How long does it take to get results, and how are they delivered?

The turnaround time is 5 weeks from sample receipt. Results are delivered via secure digital report with a comprehensive bioinformatics analysis summary. A telephonic post-test consultation with our Consultant Medical Genetics can be arranged upon request.

UAE Regulatory & Data Privacy Adherence

Data Protection & Legal Compliance

Personal data processing fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Health information handling meets the standards of Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).

All genetic and epigenetic data is encrypted, access-controlled, and processed exclusively within the UAE jurisdiction. Your data is never shared with third parties without explicit written consent.

Clinical & Logistical Metadata

Test Name	ATAC Sequencing Test (Assay for Transposase-Accessible Chromatin)
Price (AED)	6,500 AED
Turnaround Time	5 weeks
Sample Type / Matrix	Whole Blood (EDTA tube, 2–4 mL) or Extracted Genomic DNA (≥2 µg)
Methodology Used	High-sensitivity transposase-based NGS with validated bioinformatics pipeline (Illumina platform)
ICD-10-CM Code	Z01.89 (Encounter for other specified special examinations)
LOINC Code	97926-7 (Chromatin accessibility [presence] in blood or tissue by sequencing)
DHA Facility License & Laboratory Address	Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Operated by DNA Labs UAE.